1型糖尿病与骨质疏松及骨折发生之间的因果关系:两样本孟德尔随机化分析
采用两样本孟德尔随机化分析,以逆方差加权法为主要方法,评估1型糖尿病与骨质疏松及骨折风险的因果关系。结果显示1型糖尿病与骨质疏松无显著因果关联,与前臂骨折的逆方差加权结果仅为提示性显著且结果不够稳健,股骨、腰椎、骨盆及肩部上臂骨折无因果效应。
要点
- 逆方差加权法显示1型糖尿病与骨质疏松无显著因果关联(OR=1.040,95%CI=0.974-1.109,P=0.238)。
- 1型糖尿病与前臂骨折的逆方差加权结果呈提示性显著(OR=1.062,95%CI=1.010-1.117,P=0.020),但结果不够稳健。
- 1型糖尿病与股骨、腰椎、骨盆及肩部上臂骨折均无因果效应。
核心结论
- 尽管1型糖尿病可能是骨健康的危险因素,但无足够证据支持1型糖尿病在遗传预测水平上对骨质疏松和骨折存在因果效应。
- 需要纳入更多病例进行分析。
研究设计与样本
- 两样本孟德尔随机化分析,从全基因组关联荟萃分析中选取与1型糖尿病密切相关的独立单核苷酸多态性作为工具变量。
- 骨折与骨质疏松数据来自FinnGen联盟,以逆方差加权法为主要分析方法,并用MR-Egger回归和加权中位数法验证结果。
主要发现
- 逆方差加权法显示1型糖尿病与骨质疏松无显著因果关联(OR=1.040,95%CI=0.974-1.109,P=0.238),MR-Egger回归(OR=1.077,95%CI=0.921-1.260,P=0.372)和加权中位数法(OR=1.021,95%CI=0.935-1.114,P=0.643)结果一致,方向一致。
- 1型糖尿病与前臂骨折的逆方差加权结果呈提示性显著(OR=1.062,95%CI=1.010-1.117,P=0.020),但结果不够稳健。
- 1型糖尿病与股骨、腰椎和骨盆骨折及肩部上臂骨折均无因果效应。
关键数值与推荐
- 1型糖尿病与骨质疏松:逆方差加权法OR=1.040(95%CI=0.974-1.109,P=0.238),MR-Egger回归OR=1.077(95%CI=0.921-1.260,P=0.372),加权中位数法OR=1.021(95%CI=0.935-1.114,P=0.643)。
- 1型糖尿病与前臂骨折:逆方差加权法OR=1.062(95%CI=1.010-1.117,P=0.020),为提示性显著但结果不够稳健。
临床怎么用
- 原文未据此给出推荐。
局限性
- 1型糖尿病与前臂骨折的逆方差加权结果仅为提示性显著,结果不够稳健。
- 需要纳入更多病例进行分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We used two-sample Mendelian Randomization to reveal causal estimates of type 1 diabetes and bone. Type 1 diabetes was found to be a risk factor for bone metabolic health, although there was no clear evidence to support a genetic association between type 1 diabetes and osteoporosis and fracture risk. INTRODUCTION: Based on the random assignment of gametes at conception, Mendelian randomization (MR) analysis simulates randomized controlled trials in an observational setting. Therefore, we used MR to assess the association causality of type 1 diabetes (T1D) with fractures and osteoporosis. METHODS: From a genome-wide association meta-analysis, independent single nucleotide polymorphisms closely associated with T1D were selected as instrumental variables. Data on fracture and osteoporosis were obtained from the FinnGen Consortium. We performed a two-sample MR analysis, using inverse-variance weighted (IVW) as the primary analysis method, to assess possible causal associations between T1D and bone risk. The results were verified by MR-Egger regression and median weighted method (WME). MR-PRESSO and MR-Egger intercepts were used to evaluate the horizontal pleiotropy of instrumental variables, and the Q-test and "leave-one-out" methods were used to test the heterogeneity of MR results. RESULTS: IVW (OR=1.040, 95% CI=0.974-1.109, P=0.238), MR-Egger regression (OR=1.077, 95% CI=0.921-1.260, P=0.372) and WME (OR=1.021, 95% CI=0.935-1.114, P=0.643) all showed that there was no causal relationship between T1D and osteoporosis, but the direction was consistent. The indicative significance of IVW results in T1D and forearm fractures (OR=1.062, 95% CI=1.010-1.117, P=0.020), but the results are not robust enough. There was no causal effect in femur, lumbar and pelvis, or shoulder and upper arm fractures. CONCLUSIONS: After MR analysis, although T1D may be a risk factor for bone health, we do not have sufficient evidence to support a causal effect of T1D on osteoporosis and fractures at a genetically predicted level. More cases need to be included for analysis.
引用
- Tang Y, Zhang L, Ye D, et al. Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis. Osteoporos Int. 2023. PMID: 37012460. doi:10.1007/s00198-023-06734-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。